Clinical Trial

RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis

Name: RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis — clinical trial record (NCT06643780)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The objective of this study was to conduct a randomized, double-blind, double-dummy active controlled trial to determine the efficacy of denosumab in treating sarcopenia with underlying osteoporosis.

Trial Details

NCT Number	NCT06643780
Lead Sponsor	Prince of Wales Hospital, Shatin, Hong Kong Collaborators: Chinese University of Hong Kong
Conditions	Sarcopenia in Elderly
Enrollment	120 participants
Start Date	2024-04-09
Primary Completion	2027-04 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2024-10-16